Cargando…

Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

BACKGROUND: Mass drug administration (MDA) with azithromycin is the primary strategy for global trachoma control efforts. Numerous studies have reported secondary effects of MDA with azithromycin, including reductions in childhood mortality, diarrhoeal disease and malaria. Most recently, the MORDOR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickering, Harry, Hart, John D., Burr, Sarah, Stabler, Richard, Maleta, Ken, Kalua, Khumbo, Bailey, Robin L., Holland, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740015/ https://www.ncbi.nlm.nih.gov/pubmed/34991704 http://dx.doi.org/10.1186/s13099-021-00478-6

Ejemplares similares

Biannual Administrations of Azithromycin and the Gastrointestinal Microbiome of Malawian Children: A Nested Cohort Study Within a Randomized Controlled Trial
por: Chaima, David, et al.
Publicado: (2022)

Fecal biomarkers of environmental enteric dysfunction and the gut microbiota of rural Malawian children: An observational study
por: Chaima, David, et al.
Publicado: (2021)

Prevalence of nasopharyngeal Streptococcus pneumoniae carriage and resistance to macrolides in the setting of azithromycin mass drug administration: analysis from a cluster-randomised controlled trial in Malawi, 2015–17
por: Hart, John D, et al.
Publicado: (2022)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children
por: Pickering, Harry, et al.
Publicado: (2022)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
por: Bojang, Ebrima, et al.
Publicado: (2017)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

One round of azithromycin MDA adequate to interrupt transmission in districts with prevalence of trachomatous inflammation—follicular of 5.0-9.9%: Evidence from Malawi
por: Kalua, Khumbo, et al.
Publicado: (2018)

A prevalence survey of enteral parasites in preschool children in the Mangochi District of Malawi
por: Jones, Timothy P. W., et al.
Publicado: (2019)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

The prevalence and risk factors for acute respiratory infections in children aged 0‐59 months in rural Malawi: A cross‐sectional study
por: Cox, Miriam, et al.
Publicado: (2017)

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

A Trial of Three Rounds of Mass Drug Administration with Azithromycin for Yaws
por: John, Lucy N., et al.
Publicado: (2022)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Effectiveness of azithromycin mass drug administration on trachoma: a systematic review
por: Xiong, Tao, et al.
Publicado: (2021)

Mass azithromycin administration: considerations in an increasingly resistant world
por: Hooda, Yogesh, et al.
Publicado: (2020)

Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
por: Burr, Sarah E., et al.
Publicado: (2019)

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

How to create a balanced eye team: an example from Malawi
por: Kalua, Khumbo
Publicado: (2018)

The impact of mass drug administration of antibiotics on the gut microbiota of target populations
por: Gough, Ethan K.
Publicado: (2022)

Prevalence and Risk Factors for Trachoma in Central and Southern Malawi
por: Kalua, Khumbo, et al.
Publicado: (2010)

Mass Azithromycin Distribution and Community Microbiome: A Cluster-Randomized Trial
por: Doan, Thuy, et al.
Publicado: (2018)

Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial
por: Roca, Anna, et al.
Publicado: (2015)

Dose and formulation of azithromycin in mass drug administration studies: a systematic review protocol
por: Yue, Yan, et al.
Publicado: (2019)

Mass Drug Administration of Azithromycin to Reduce Child Mortality: Only for High-Mortality Settings?
por: Tickell, Kirkby D., et al.
Publicado: (2020)

Prevalence of Scabies and Impetigo 3 Years After Mass Drug Administration With Ivermectin and Azithromycin
por: Marks, Michael, et al.
Publicado: (2020)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

A Cross-Sectional Study of ‘Yaws’ in Districts of Ghana Which Have Previously Undertaken Azithromycin Mass Drug Administration for Trachoma Control
por: Ghinai, Rosanna, et al.
Publicado: (2015)

Common antibiotics, azithromycin and amoxicillin, affect gut metagenomics within a household
por: Chopyk, Jessica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8lk3l3kpo1do46891cclq0h3mn